Work

Abstract 28: Phase I trial of combined temsirolimus, erlotinib, and cisplatin in advanced solid tumors.

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2013-28

Authors: Matthew A. Maurer, Kevin Kalinsky, Katherine Crew, Ramona Jayasena, Julia Forman, Ying-Ka Lau, Ramon Parsons, Dawn Hershman

Institution: Columbia University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2328032903

Cites:

Cited by: 3

Related to: 10